Results 11 to 20 of about 1,977,831 (264)

Oncogene-mediated metabolic gene signature predicts breast cancer outcome

open access: yesnpj Breast Cancer, 2021
Breast cancer remains the second most lethal cancer among women in the United States and triple-negative breast cancer is the most aggressive subtype with limited treatment options.
Merve Aslan   +13 more
doaj   +1 more source

Early detection and therapeutics [PDF]

open access: yesMolecular Oncology, 2019
Early detection, including cancer screening and surveillance, is emerging as one of the most important topics in modern oncology. Because symptomatic presentation remains the predominant route to cancer diagnosis, there is a growing interest in developing techniques to detect the disease at an early, curative stage.
Januszewicz, Wladyslaw   +1 more
openaire   +3 more sources

The value of ultrasound to differentiate between benign and malignant duct ectasia

open access: yesمجلة كلية الطب, 2014
Background: Mammary duct ectasia is defined as dilated duct larger than 2 mm in diameter seen in fibrocystic changes, ductal epithelial hyperplasia, papiloma, DCIS. US has a significant role in diagnostic breast imaging.
Enam A. AL -Tememy   +3 more
doaj   +1 more source

Cancer burden and status of cancer control measures in fragile states: a comparative analysis of 31 countries

open access: yesThe Lancet Global Health, 2022
Summary: Background: Information on cancer statistics and cancer control policies is limited in fragile states. This paper describes the cancer burden and status of cancer control measures in these countries.
Isabel Mosquera, PhD   +4 more
doaj   +1 more source

Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India

open access: yeseLife, 2023
Local cervical cancer epidemiological data essential to project the context-specific impact of cervical cancer preventive measures are often missing. We developed a framework, hereafter named Footprinting, to approximate missing data on sexual behaviour,
Irene Man   +3 more
doaj   +1 more source

The added role of contrast-enhanced spectral mammography in the evaluation of pathological nipple discharge

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2022
Background Nipple discharge is one of the commonest encountered complaints in the field of breast imaging. Excluding malignancy as a cause of pathological nipple discharge is of utmost importance.
Sherihan Fakhry   +5 more
doaj   +1 more source

Microbubble–Nanoparticle Complexes for Ultrasound-Enhanced Cargo Delivery

open access: yesPharmaceutics, 2022
Targeted delivery of therapeutics to specific tissues is critically important for reducing systemic toxicity and optimizing therapeutic efficacy, especially in the case of cytotoxic drugs.
Rachel Chapla   +2 more
doaj   +1 more source

Estimating the prevalence of Epstein–Barr virus in primary gastric lymphoma: a systematic review and meta-analysis

open access: yesInfectious Agents and Cancer, 2023
The stomach is a common site for extranodal non-Hodgkin’s lymphoma. While Helicobacter pylori (H. pylori) is the main established risk factor for primary gastric lymphoma, a fraction could be aetiologically associated with Epstein–Barr virus (EBV), a ...
Mayo Hirabayashi   +4 more
doaj   +1 more source

Irreversible alteration of extracellular vesicle and cell-free messenger RNA profiles in human plasma associated with blood processing and storage

open access: yesScientific Reports, 2022
The discovery and utility of clinically relevant circulating biomarkers depend on standardized methods that minimize preanalytical errors. Despite growing interest in studying extracellular vesicles (EVs) and cell-free messenger RNA (cf-mRNA) as ...
Hyun Ji Kim   +9 more
doaj   +1 more source

Early detection: introduction [PDF]

open access: yesEuropean Respiratory Journal, 2003
The present Supplement of the European Respiratory Journal assembles a number of reviews on “Early detection” and it is the product of a symposium held in Barcelona on June 22 2002. The symposium was organised by the European Institute of Healthcare, which was set up by AstraZeneca.
M, Decramer, C, Roussos
openaire   +2 more sources

Home - About - Disclaimer - Privacy